Jane I. Pernes

Jane I. Pernes

Auto-generated profile, based on publicly available information

Jane I. Pernes

School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2020 in Science Signaling
Verified
Journal Article
Closed access
RARachel Ambler
Rachel Ambler
GEGrace Edmunds
Grace Edmunds
STSin Lih Tan
Sin Lih Tan
SCSilvia Cirillo
Silvia Cirillo
JPJane I. Pernes
Jane I. Pernes
CWChristoph Wulfing
Christoph Wulfing
PD-1 signaling suppresses tumor-infiltrating lymphocytes by destabilizing their interactions with target tumor cells.

20 June 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DCDanilo Correddu
Danilo Correddu
JLJosé de Jesús Montaño López
José de Jesús Montaño López
PVPraveen G. Vadakkedath
Praveen G. Vadakkedath
ALAmy Lai
Amy Lai
JPJane I. Pernes
Jane I. Pernes
Ivanhoe LeungIvanhoe Leung
Ivanhoe Leung
Human ribosomal proteins play important structural and functional roles in the ribosome and in protein synthesis. An efficient method to recombinantly produce and purify these proteins would enable their full characterisation. However, the production of human ribosomal proteins can be challenging. The only published method about the recombinant production of human ribosomal proteins involved the recovery of proteins from inclusion bodies, a process that is tedious and may lead to significant loss of yield. Herein, we explored the use of different Escherichia coli competent cells and fusion protein tags for the recombinant production of human ribosomal proteins. We found that, by using thioredoxin as a fusion protein, soluble ribosomal protein could be obtained directly from cell lysates, thus leading to an improved method to recombinantly produce these proteins.